Contact
 

Mitchell Warren, Executive Director of AVAC, wrote a piece for the Huffington Post calling for the celebration of the possibility of an AIDS vaccine. Please click here to read the piece...

Mark Wainberg, the Director of the McGill University AIDS Centre, wrote an editorial for the Windsor Star applauding Canada in its early support of AIDS vaccine research and urging its continued leadership as a technical and funding partner....

A Phase 1 study of a preventive HIV vaccine show that a novel delivery mechanism known as electroporation helped to enhance the immunogenicity of the vaccine tested. Results were presented at the end of October at the AIDS Vaccine Conference in...

Visit the new AVAC web site: www.avac.org. The site contains AVAC’s comprehensive coverage of the full range of biomedical HIV prevention interventions in an easy-to-use format that is...

The first International Symposium on Natural Immunity to HIV (ISNIH) will be held in Winnipeg, Canada from November 15 - 17, 2009. The conference is sponsored by the Bill & Melinda Gates Foundation, the University of Manitoba and the Public...

To support the Global HIV Vaccine Enterprise’s efforts to raise the visibility and participation in the HIV vaccine field of Young and Early Career Investigators, the CAVD recognizes the young or early career investigators who have made...

Researchers, funders policy makers and advocates from around the world gathered in Paris for today’s opening of AIDS Vaccine 2009, the world’s leading scientific conference on AIDS vaccine research.

The International AIDS Vaccine Initiative (IAVI) announced today that it has signed a memorandum of understanding with the Ragon Institute to accelerate the development of new and promising AIDS vaccine candidates for testing

Results of the Thai HIV vaccine clinical trial of the “prime-boost” combination of ALVAC-HIV vaccine and AIDSVAC B/E vaccine demonstrate that a safe and effective AIDS vaccine is an achievable goal. For more information, please see the Enterprise...

The minutes from the September 17 and 18 meeting of the Host Genetics and HIV Diversity Working Group can be found below. Recommendations from this working group will comprise a portion of the 2010 Scientific Strategic Plan for HIV vaccine...

Global HIV Vaccine Enterprise, 64 Beaver Street, # 352, New York, NY 10004 | +1 212-461-3692 or toll free at +1-866-966-4483
All Content ©2005 - 2013 Global HIV Vaccine Enterprise   |   Terms of Use   |   Privacy Policy   |   Log In / My Account